EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-regional transcriptomic profiling reveals divergent molecular mechanisms in ALS-related neurodegeneration

Yu-Wen Hsu iD, Yu-Ning Lu iD, Mingming Liu iD, Jiou Wang iD

PLOS Genetics · 08.07.2026 · 22 (7) · e1012225

DOI: 10.1371/journal.pgen.1012225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Genetics, online erschienen am 08.07.2026. Verfasst von Yu-Wen Hsu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of …. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, C9orf72 Protein, Transcriptome. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Health, the Walder Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative disorders including amyotrophic lateral sclerosis (ALS) remain largely unsolved, with complex etiology yet to be fully elucidated. The most common genetic cause of ALS in both familial and sporadic cases is the expansion of a hexanucleotide repeat in the C9orf72 gene. To systematically dissect the molecular landscape of ALS, we performed integrative transcriptomic analyses across multiple central nervous system regions from ALS patients carrying pathological C9orf72 repeat expansions (ALS-C9) and those without the mutation (ALS-non-C9). In parallel, we performed transcriptome-wide cell-type deconvolution to assess the cellular composition of neuronal and non-neuronal populations. We identified a set of dysregulated molecular pathways that were consistently altered in both ALS-C9 and ALS-non-C9 patients, suggesting shared pathogenic mechanisms. Distinct gene-specific alterations also pointed to divergent subtype-dependent molecular trajectories. Gene-specific alterations were also associated with short clinical duration in ALS-non-C9, highlighting a sex-dependent immunological contribution to disease outcome. Our cross-regional integrative transcriptomic analyses reveal both convergent and divergent molecular and cellular features between ALS-C9 and ALS-non-C9 subgroups, underscoring the clinical heterogeneity of ALS and providing a framework for subtype- and sex-specific therapeutic stratifications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisC9orf72 ProteinTranscriptomeHumansGene Expression ProfilingDNA Repeat ExpansionFemaleMutation

Substanzen

C9orf72 ProteinC9orf72 protein, human

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Department of Neuroscience, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.

ORCID-Profile: Yu-Wen Hsu, Yu-Ning Lu, Mingming Liu, Jiou Wang

Förderung

  • NINDS NIH HHS
  • National Institute of Health
  • the Walder Foundation
  • The Packard Center for ALS Research at Johns Hopkins
  • Maryland Stem Cell Research Fund

Zitieren

APA

Hsu, Y. W., Lu, Y. N., Liu, M., & Wang, J. (2026). Multi-regional transcriptomic profiling reveals divergent molecular mechanisms in ALS-related neurodegeneration. PLOS Genetics, 22(7), e1012225. https://doi.org/10.1371/journal.pgen.1012225

Vancouver

Hsu YW, Lu YN, Liu M, Wang J. Multi-regional transcriptomic profiling reveals divergent molecular mechanisms in ALS-related neurodegeneration. PLOS Genetics. 2026;22(7):e1012225. doi:10.1371/journal.pgen.1012225

BibTeX
@article{Hsu2026,
  author = {Hsu, Yu-Wen and Lu, Yu-Ning and Liu, Mingming and Wang, Jiou},
  title = {Multi-regional transcriptomic profiling reveals divergent molecular mechanisms in ALS-related neurodegeneration},
  journal = {PLOS Genetics},
  year = {2026},
  volume = {22},
  number = {7},
  pages = {e1012225},
  doi = {10.1371/journal.pgen.1012225}
}
Kostenlos starten →